1. What is the Orange Healthcare Glycophorin (Erythroid Cell Marker) Test?
It is a specialised laboratory test used to detect glycophorin, commonly glycophorin A, to identify cells of erythroid origin in tissue or bone marrow specimens.
2. Why is the Glycophorin (Erythroid Cell Marker) Test performed?
The test is performed to identify erythroid cells, investigate suspected erythroid leukaemia, evaluate abnormal bone marrow findings, and help distinguish erythroid cells from other haematopoietic cell populations.
3. What does a positive Glycophorin result indicate?
A positive result indicates the presence of cells expressing glycophorin, supporting erythroid differentiation. It may help identify erythroid components in certain haematological disorders but does not independently confirm malignancy.
4. What does a negative Glycophorin result indicate?
A negative result indicates that glycophorin expression was not detected in the examined cells. This may suggest a non-erythroid cell population, although some immature or abnormal erythroid cells may show weak or absent expression.
5. Is fasting required for the Orange Healthcare Glycophorin Test?
Fasting is generally not required for the laboratory analysis. However, patients undergoing a bone marrow biopsy or another specimen collection procedure should follow their healthcare providers preparation instructions.
6. What sample is required for the Glycophorin (Erythroid Cell Marker) Test?
A bone marrow biopsy or tissue specimen is commonly required. The sample is typically examined using immunohistochemistry (IHC) with antibodies against glycophorin A to identify erythroid cells and assess their distribution within the specimen.